Dupont Capital Management Corp Standard Biotools Inc. Transaction History

Dupont Capital Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$1.6 - $3.99 $70,545 - $175,923	-44,091 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$2.8 - $3.96 $10,920 - $15,444	-3,900 Reduced 8.13%	44,091 $158,000
Q4 2021 Jan 31, 2022	BUY	$3.63 - $6.13 $28,756 - $48,561	7,922 Added 19.77%	47,991 $188,000
Q3 2021 Nov 03, 2021	SELL	$5.5 - $7.41 $31,152 - $41,970	-5,664 Reduced 12.38%	40,069 $264,000
Q2 2021 Jul 30, 2021	BUY	$4.35 - $6.35 $198,938 - $290,404	45,733 New	45,733 $282,000
Q3 2020 Oct 29, 2020	SELL	$4.34 - $11.43 $330,907 - $871,491	-76,246 Closed	0 $0
Q2 2020 Jul 24, 2020	SELL	$1.85 - $5.29 $227,477 - $650,463	-122,961 Reduced 61.73%	76,246 $306,000
Q4 2019 Jan 27, 2020	BUY	$2.3 - $5.12 $318,612 - $709,258	138,527 Added 228.29%	199,207 $693,000
Q3 2019 Oct 28, 2019	BUY	$4.63 - $12.15 $68,014 - $178,483	14,690 Added 31.94%	60,680 $281,000
Q2 2019 Jul 30, 2019	BUY	$11.49 - $14.17 $528,425 - $651,678	45,990 New	45,990 $567,000

144

270M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $115M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.